Mayne Pharma Group(DE:HG6)
€1.96-0.03 (-1.51%)
DE:HG6
Mayne Pharma Group financials statements
€1.96
At close:-0.03 (-1.51%)
Mayne Pharma Group (HG6) Income Statement
0 Followers
Mayne Pharma Group Income Statement
Last quarter (Q4 2026), Mayne Pharma Group's total revenue was AU$171.61M, a decrease of 14.40% from the same quarter last year. In Q4, Mayne Pharma Group's net income was AU$39.41M. See Mayne Pharma Group’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| AU$ 383.68M | AU$ 408.10M | AU$ 388.15M | AU$ 183.59M | AU$ 157.15M | |
| AU$ 192.21M | AU$ 247.27M | AU$ 218.53M | AU$ 26.84M | AU$ 23.75M | |
| AU$ 226.49M | AU$ 270.87M | AU$ 357.59M | AU$ 213.28M | AU$ 145.62M | |
| Depreciation and Amortization | AU$ 63.69M | AU$ 69.27M | AU$ 68.46M | AU$ 65.44M | AU$ 55.18M |
| AU$ 29.40M | AU$ 47.24M | AU$ -116.93M | AU$ -193.80M | AU$ -78.88M | |
| AU$ -34.28M | AU$ -23.59M | AU$ -139.06M | AU$ -186.44M | AU$ -121.88M | |
| AU$ 70.04M | AU$ -59.70M | AU$ -51.02M | AU$ -83.25M | AU$ -23.71M | |
| AU$ 35.76M | AU$ -83.30M | AU$ -190.09M | AU$ -269.70M | AU$ -145.59M | |
| AU$ 24.47M | AU$ -93.84M | AU$ -174.23M | AU$ 117.25M | AU$ -281.29M | |
| Per Share Metrics | |||||
| Basic EPS | AU$ 0.31 | AU$ -1.14 | AU$ -2.19 | AU$ -3.89 | AU$ -3.46 |
| Diluted EPS | AU$ 0.21 | AU$ -1.14 | AU$ -2.19 | AU$ -3.89 | AU$ -3.46 |
| Weighted Average Shares Outstanding | 79.94M | 79.14M | 79.62M | 81.25M | 81.25M |
| Weighted Average Shares Outstanding (Diluted) | 106.29M | 79.14M | 79.62M | 81.25M | 81.25M |
Currency in AUD
